Relationship Between Nail Psoriasis Severity Index and Cardiovascular Risk Assessed by 10 Cardiovascular Risk Calculators
- PMID: 40462257
- DOI: 10.1002/msc.70136
Relationship Between Nail Psoriasis Severity Index and Cardiovascular Risk Assessed by 10 Cardiovascular Risk Calculators
Abstract
Objective: To determine the relationship between Nail Psoriasis Severity Index (NAPSI) and cardiovascular risk (CVR) assessed by 10 CVR calculators.
Methods: Cross-sectional, observational, and comparative study of psoriatic arthritis (PsA) patients aged 30-75, classified according to established diagnostic criteria. The NAPSI was assessed, classifying patients into two groups: with (≥ 1) and without (< 1) nail involvement. The CVR was evaluated through: Framingham (FRS) lipids and body mass index (BMI), American College of Cardiology/American Heart Association- Atherosclerotic Cardiovascular Disease 2013 (ACC/AHA ASCVD 2013), Systematic Coronary Risk Evaluation (SCORE), SCORE 2, SCORE-Older Persons (OP), QRISK3, Reynolds Risk Score (RRS), Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) atherosclerotic cardiovascular disease (ASCVD) and PREVENT Heart Failure (HF) calculator. Group distribution was assessed using the Kolmogorov-Smirnov test. Comparisons were conducted accordingly with Chi-Squared, T-Student, U-Mann-Whitney, and Kruskal-Wallis tests. Correlations were performed using Spearman's rho. Statistical significance was set at p ≤ 0.05.
Results: Seventy-one patients with PsA were included, 31 with nail involvement and 40 without. CVR score was higher in PsA patients with nail involvement using SCORE (2.0 (1.0-3.7) versus 1.0 (0.0-2.0), p = 0.02). Regarding CVR, positive correlations were found between NAPSI and the following calculators: ACC/AHA ASCVD 2013 (Spearman's rho = 0.202, p = 0.045), FRS BMI (Spearman's rho = 0.229, p = 0.027), SCORE (Spearman's rho = 0.344, p = 0.002), PREVENT ASCVD (Spearman's rho = 0.198, p = 0.049), and PREVENT HF (Spearman's rho = 0.291, p = 0.007).
Conclusions: A NAPSI ≥ 1 score is related to higher CVR assessed through SCORE and positively correlates with ACC/AHA, PREVENT TM ASCVD, and PREVENT HF.
Keywords: cardiovascular diseases; cardiovascular risk assessment; nail psoriasis; psoriatic arthritis.
© 2025 John Wiley & Sons Ltd.
References
-
- Alcocer, L. A., O. Lozada, G. Fanghänel, L. Sánchez‐Reyes, and E. Campos‐Franco. 2011. “Estratificación del riesgo cardiovascular global. Comparación de los métodos Framingham y SCORE en población mexicana del estudio PRIT.” Cirugía y Cirujanos 79, no. 2: 168–174. https://www.redalyc.org/articulo.oa?id=66221099010.
-
- Arif, A., I. D. Roesyanto Mahadi, and A. Yosi. 2021. “Correlation Between Nail Psoriasis Severity Index Score With Quality of Life in Nail Psoriasis.” Bali Medical Journal 10, no. 1: 256–260. https://doi.org/10.15562/bmj.v10i1.2198.
-
- Colunga‐Pedraza, I. J., D. A. Galarza‐Delgado, J. R. Azpiri‐Lopez, et al. 2021. “Nail Involvement in Psoriatic Arthritis Patients Is an Independent Risk Factor for Carotid Plaque.” Annals of the Rheumatic Diseases 80, no. 12: 1629–1631. https://doi.org/10.1136/annrheumdis‐2021‐220782.
-
- Crossan, C., J. Lord, R. Ryan, L. Nherera, and T. Marshall. 2016. “Cost‐effectiveness of Case‐Finding Strategies for Primary Prevention of Cardiovascular Disease: A Modelling Study.” British Journal of General Practice 67, no. 654: e67–e77. https://doi.org/10.3399/bjgp16x687973.
-
- de Vries, T. I., M. T. Cooney, R. M. Selmer, et al. 2021. “SCORE2‐OP Risk Prediction Algorithms: Estimating Incident Cardiovascular Event Risk in Older Persons in Four Geographical Risk Regions.” European Heart Journal 42, no. 25: 2455–2467. https://doi.org/10.1093/eurheartj/ehab312.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
